Bieke Decaesteker
No current affiliation with UGent
- ORCID iD
-
0000-0003-2264-781X
Show
Sort by
-
- Journal Article
- A1
- open access
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
-
- Journal Article
- A2
- open access
From Delta to Omicron SARS-CoV-2 variant : switch to saliva sampling for higher detection rate
-
- Journal Article
- A1
- open access
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
-
The adrenergic-specific long non-coding RNA NESPR controls survival of neuroblastoma cells
-
RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
-
Cellular senescence in neuroblastoma
-
- Journal Article
- A1
- open access
From DNA copy number gains and tumor dependencies to novel therapeutic targets for high-risk neuroblastoma
-
- Journal Article
- A1
- open access
MEIS2 is an adrenergic core regulatory transcription factor involved in early initiation of TH-MYCN-driven neuroblastoma formation
-
- Journal Article
- A1
- open access
MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells
-
SOX11 as guardian of epigenetic plasticity in neuroblastoma
-
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
-
Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions
-
The functional annotation and exploration the SOX11 enhanceosome
-
SOX11 as guardian of epigenetic plasticity in neuroblastoma
-
Long noncoding RNA SILC1 is an upstream regulator of SOX11 in neuroblastoma
-
MYCN activation in hTERT immortalized RPE cells as model for oncogene induced senescence
-
SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma
-
SOX11 as mediator of the adrenergic cell state in NB
-
SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma
-
DREAM target reactivation by core transcriptional regulators supports neuroblastoma growth
-
Core regulatory circuitries and epigenetic plasticity in neuroblastoma
(2019) -
- Journal Article
- A1
- open access
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
-
ALK positively regulates MYCN activity through repression of HBP1 expression
-
MYCN activation in hTERT immortalized RPE cells as model for oncogene induced senescence
-
- Journal Article
- A1
- open access
In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
-
- Journal Article
- A1
- open access
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
-
- Journal Article
- A1
- open access
Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice
-
TBX2 is implicated in cell cycle control and proliferation in neuroblastoma
-
The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma
-
SOX11 is a transcriptional circuit dosage sensitive transcription factor controlling SWI/SNF components
-
The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma
-
The RRM2-PHF6 complex protects neuroblastoma cells from DNA damage accumulation to install a replication stress resistance phenotype
-
- Journal Article
- A1
- open access
A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing
-
Network modeling of microRNA-mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN
-
SOX11 acts as part of the MYCN-WEE1 regulatory protein complex implicated in neuroblastoma
-
RRM2 is an essential and druggable component of the FOXM1 driven replicative stress DNA damage response in neuroblastoma
-
RRM2 is an essential and druggable component of the FOXM1 driven replicative stress DNA damage response in neuroblastoma
-
The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma
-
SOX11 acts as part of the MYCN-WEE1 regulatory protein complex implicated in neuroblastoma
-
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex
-
The HBP1 tumour suppressor is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex
-
HBP1 is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex
-
The BRIP1/FANCJ DNA helicase is a druggable 17q driver oncogene involved in G-quadruplex induced replicative stress resistance in neuroblastoma
-
Optimization of a lentiviral inducible CRISPR/Cas9 system to modulate genes essential for sustained growth of cells
-
The chromosome 17q super-enhancer landscape in neuroblastoma
-
The TBX2 super-enhancer marked transcription factor on 17q is overexpressed in neuroblastoma and infers poor prognosis
-
SOX11 acts as part of the MYCN regulatory protein complex implicated in neuroblastoma
-
The TBX2 super-enhancer marked transcription factor on 17q is overexpressed in neuroblastoma and infers poor prognosis
-
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex
-
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex
-
The genomic region encompassing the overlapping SOX11 and Lnc-SOX11-1:1 loci exhibits a complex DNA copy number and mRNA expression pattern
-
The chromosome 17q super-enhancer landscape in neuroblastoma
-
The chromosome 17q super-enhancer landscape in neuroblastoma
-
SOX11 is a lineage-survival oncogene in neuroblastoma
-
SOX11 is a lineage-survival oncogene in neuroblastoma
-
SOX11 is a lineage-survival oncogene in neuroblastoma
-
SOX11 is a lineage-survival oncogene in neuroblastoma